An alternative temperature-based histamine-sensitisation test for absence of residual pertussis toxin in acellular pertussis vaccines.
As an extension of the BSP076 study (see the article 'Collaborative Study for the Standardisation of the Histamine Sensitizing Test in Mice and the CHO Cell-based Assay for the Residual Toxicity Testing of Acellular Pertussis Vaccines (BSP076)', page 51 of this issue of Pharmeuropa Bio & Scientific Notes), it was decided to publish the following experimental method for the temperature-based histamine-sensitisation test, validated at the SSI (Statens Serum Institut, Denmark), as a working basis for the growth of the method in individual laboratories.
Jensen
S E
SE
Engelhart Illigen
K E
KE
Hasløv
K R
KR
D023401:Animal Use Alternatives; D000818:Animals; D001681:Biological Assay / Q000379:methods* / Q000592:standards; D001831:Body Temperature / Q000187:drug effects; D002138:Calibration; D004305:Dose-Response Relationship, Drug; D005260:Female; D006632:Histamine / Q000008:administration & dosage / Q000276:immunology / Q000633:toxicity*; D007753:Laboratories / Q000592:standards; D051379:Mice; D008810:Mice, Inbred C57BL; D037342:Pertussis Toxin / Q000032:analysis* / Q000276:immunology; D010567:Pertussis Vaccine / Q000276:immunology / Q000592:standards* / Q000633:toxicity; D012015:Reference Standards; D013817:Thermography; D018675:Toxicity Tests / Q000379:methods* / Q000592:standards; D022282:Vaccines, Acellular / Q000276:immunology / Q000592:standards* / Q000633:toxicity
D010567:Pertussis Vaccine; D022282:Vaccines, Acellular; D006632:Histamine; D037342:Pertussis Toxin